{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T02:44:26Z","timestamp":1767926666116,"version":"3.49.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,4,17]],"date-time":"2012-04-17T00:00:00Z","timestamp":1334620800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1186\/2047-783x-17-7","type":"journal-article","created":{"date-parts":[[2012,4,17]],"date-time":"2012-04-17T10:14:27Z","timestamp":1334657667000},"source":"Crossref","is-referenced-by-count":11,"title":["Caspofungin for treatment of invasive aspergillosis in Germany: results of a pre-planned subanalysis of an international registry"],"prefix":"10.1186","volume":"17","author":[{"given":"Gerlinde","family":"Egerer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dietmar","family":"Reichert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mathias W","family":"Pletz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Kaskel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karl J","family":"Krobot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johan","family":"Maertens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,4,17]]},"reference":[{"key":"6_CR1","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s00277-008-0622-5","volume":"88","author":"A B\u00f6hme","year":"2009","unstructured":"B\u00f6hme A, Ruhnke M, Buchheidt D, Cornely OA, Einsele H, Enzensberger R, Hebart H, Heinz W, Junghanss C, Karthaus M, Kr\u00fcger W, Krug U, Kubin T, Penack O, Reichert D, Reuter S, Silling G, S\u00fcdhoff T, Ullmann AJ, Maschmeyer G, Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO): Treatment of invasive fungal infections in cancer patients - recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO). Ann Hematol 2009, 88: 97\u2013110. 10.1007\/s00277-008-0622-5","journal-title":"Ann Hematol"},{"key":"6_CR2","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.2165\/00003495-200868140-00002","volume":"68","author":"MJ R\u00fcping","year":"2008","unstructured":"R\u00fcping MJ, Vehreschild JJ, Cornely OA: Patients at high risk of invasive fungal infections: when and how to treat. Drugs 2008, 68: 1941\u20131962. 10.2165\/00003495-200868140-00002","journal-title":"Drugs"},{"key":"6_CR3","doi-asserted-by":"publisher","first-page":"875","DOI":"10.2174\/138945005774912717","volume":"6","author":"A Brakhage","year":"2005","unstructured":"Brakhage A: Systemic fungal infections caused by Aspergillus species. Curr Drug Targets 2005, 6: 875\u2013886. 10.2174\/138945005774912717","journal-title":"Curr Drug Targets"},{"key":"6_CR4","first-page":"501","volume":"105","author":"K Donhuijsen","year":"2008","unstructured":"Donhuijsen K, Petersen P, Schmid KW: Trendwende in der Mykosefrequenz bei h\u00e4matologischen Neoplasien: Obduktionsergebnisse von 1976 bis 2005. Dtsch Arztebl 2008, 105: 501\u2013506.","journal-title":"Dtsch Arztebl"},{"key":"6_CR5","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1038\/bmt.2010.175","volume":"46","author":"J Maertens","year":"2011","unstructured":"Maertens J, Marchetti O, Herbrecht R, Cornely OA, Fl\u00fcckiger U, Fr\u00eare P, Gachot B, Heinz WJ, Lass-Fl\u00f6rl C, Ribaud P, Thiebaut A, Cordonnier C: Third European Conference on Infections in Leukemia. European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients: summary of the ECIL 3 - 2009 update. Bone Marrow Transplant 2011, 46: 709\u2013718. 10.1038\/bmt.2010.175","journal-title":"Bone Marrow Transplant"},{"key":"6_CR6","unstructured":"MSD SHARP & DOHME GmbH (Haar, Juli 2009): Fachinformation CANCIDAS\u00ae50 mg\/70 mg Pulver f\u00fcr ein Konzentrat zur Herstellung einer Infusionsl\u00f6sung."},{"key":"6_CR7","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1186\/1471-2334-10-182","volume":"10","author":"J Maertens","year":"2010","unstructured":"Maertens J, Egerer G, Shin W, Reichert D, Stek M, Chandwani S, Shivaprakash M, Viscoli C: Caspofungin use in daily clinical practice for treatment of invasive aspergillosis: results of a prospective observational registry. BMC Infect Dis 2010, 10: 182. 10.1186\/1471-2334-10-182","journal-title":"BMC Infect Dis"},{"key":"6_CR8","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1086\/323335","volume":"34","author":"S Ascioglu","year":"2002","unstructured":"Ascioglu S, Rex JH, de Pauw B, Bennett JE, Bille J, Crokaert F, Denning DW, Donnelly JP, Edwards JE, Erjavec Z, Fiere D, Lortholary O, Maertens J, Meis JF, Patterson TF, Ritter J, Selleslag D, Shah PM, Stevens DA, Walsh TJ, Invasive Fungal Infections Cooperative Group of the European Organization for Research and Treatment of Cancer; Mycoses Study Group of the National Institute of Allergy and Infectious Diseases: Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis 2002, 34: 7\u201314. 10.1086\/323335","journal-title":"Clin Infect Dis"},{"key":"6_CR9","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1086\/423381","volume":"39","author":"J Maertens","year":"2004","unstructured":"Maertens J, Raad I, Petrikkos G, Boogaerts M, Selleslag D, Petersen FB, Kartsonis NA, Ngai A, Taylor A, Patterson TF, Denning DW, Walsh TJ, Caspofungin Salvage Aspergillosis Study Group: Efficacy and safety of caspofungin for treatment of invasive aspergillosis in patients refractory to or intolerant of conventional antifungal therapy. Clin Infect Dis 2004, 39: 1563\u20131571. 10.1086\/423381","journal-title":"Clin Infect Dis"},{"key":"6_CR10","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1056\/NEJMoa040446","volume":"351","author":"TJ Walsh","year":"2004","unstructured":"Walsh TJ, Teppler H, Donowitz GR, Maertens JA, Baden LR, Dmoszynska A, Bourque MR, Lupinacci RJ, Sable CA, DePauw BE: Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia. N Engl J Med 2004, 351: 1391\u20131402. 10.1056\/NEJMoa040446","journal-title":"N Engl J Med"},{"key":"6_CR11","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1038\/bmt.2009.334","volume":"45","author":"R Herbrecht","year":"2010","unstructured":"Herbrecht R, Maertens J, Baila L, Aoun M, Heinz W, Martino R, Schwartz S, Ullmann AJ, Meert L, Paesmans M, Marchetti O, Akan H, Ameye L, Shivaprakash M, Viscoli C: Caspofungin first-line therapy for invasive aspergillosis in allogeneic hematopoietic stem cell transplant patients: an European Organisation for Research and Treatment of Cancer study. Bone Marrow Transplant 2010, 45: 1227\u20131233. 10.1038\/bmt.2009.334","journal-title":"Bone Marrow Transplant"},{"key":"6_CR12","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1093\/jac\/dkp355","volume":"64","author":"C Viscoli","year":"2009","unstructured":"Viscoli C, Herbrecht R, Akan H, Baila L, Sonet A, Gallamini A, Giagounidis A, Marchetti O, Martino R, Meert L, Paesmans M, Ameye L, Shivaprakash M, Ullmann AJ, Maertens J, Infectious Disease Group of the EORTC: An EORTC Phase II study of caspofungin as first-line therapy of invasive aspergillosis in haematological patients. J Antimicrob Chemother 2009, 64: 1274\u20131281. 10.1093\/jac\/dkp355","journal-title":"J Antimicrob Chemother"},{"key":"6_CR13","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1111\/j.1600-0609.2005.00500.x","volume":"75","author":"A Candoni","year":"2005","unstructured":"Candoni A, Mestroni R, Damiani D, Tiribelli M, Michelutti A, Silvestri F, Castelli M, Viale P, Fanin R: Caspofungin as first line therapy of pulmonary invasive fungal infections in 32 immunocompromised patients with hematologic malignancies. Eur J Haematol 2005, 75: 227\u2013233. 10.1111\/j.1600-0609.2005.00500.x","journal-title":"Eur J Haematol"},{"key":"6_CR14","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1056\/NEJMoa020191","volume":"347","author":"R Herbrecht","year":"2002","unstructured":"Herbrecht R, Denning DW, Patterson TF, Bennett JE, Greene RE, Oestmann JW, Kern WV, Marr KA, Ribaud P, Lortholary O, Sylvester R, Rubin RH, Wingard JR, Stark P, Durand C, Caillot D, Thiel E, Chandrasekar PH, Hodges MR, Schlamm HT, Troke PF, de Pauw B, Invasive Fungal Infections Group of the European Organisation for Research and Treatment of Cancer and the Global Aspergillus Study Group: Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med 2002, 347: 408\u2013415. 10.1056\/NEJMoa020191","journal-title":"N Engl J Med"},{"key":"6_CR15","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1086\/514341","volume":"44","author":"OA Cornely","year":"2007","unstructured":"Cornely OA, Maertens J, Bresnik M, Ebrahimi R, Ullmann AJ, Bouza E, Heussel CP, Lortholary O, Rieger C, Boehme A, Aoun M, Horst HA, Thiebaut A, Ruhnke M, Reichert D, Vianelli N, Krause SW, Olavarria E, Herbrecht R, AmBiLoad Trial Study Group: Liposomal amphotericin B as initial therapy for invasive mold infection: a randomized trial comparing a high-loading dose regimen with standard dosing (AmBiLoad trial). Clin Infect Dis 2007, 44: 1289\u20131297. 10.1086\/514341","journal-title":"Clin Infect Dis"},{"key":"6_CR16","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1086\/431586","volume":"41","author":"MA Fischer","year":"2005","unstructured":"Fischer MA, Winkelmayer WC, Rubin RH, Avorn J: The hepatotoxicity of antifungal medications in bone marrow transplant recipients. Clin Infect Dis 2005, 41: 301\u2013307. 10.1086\/431586","journal-title":"Clin Infect Dis"},{"key":"6_CR17","doi-asserted-by":"publisher","first-page":"e29","DOI":"10.1086\/505969","volume":"43","author":"AJ Ullmann","year":"2006","unstructured":"Ullmann AJ, Sanz MA, Tramarin A, Barnes RA, Wu W, Gerlach BA, Krobot KJ, Gerth WC, Longitudinal Evaluation of Antifungal Drugs (LEAD I) Investigators: Prospective study of amphotericin B formulations in immunocompromised patients in 4 European countries. Clin Infect Dis 2006, 43: e29-e38. 10.1086\/505969","journal-title":"Clin Infect Dis"},{"key":"6_CR18","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1093\/jac\/dkh434","volume":"54","author":"M Cuenca-Estrella","year":"2004","unstructured":"Cuenca-Estrella M: Combinations of antifungal agents in therapy - what value are they? J Antimicrob Chemother 2004, 54: 854\u2013869. 10.1093\/jac\/dkh434","journal-title":"J Antimicrob Chemother"},{"key":"6_CR19","doi-asserted-by":"publisher","first-page":"2740","DOI":"10.1002\/cncr.23109","volume":"110","author":"D Caillot","year":"2007","unstructured":"Caillot D, Thi\u00e9baut A, Herbrecht R, de Botton S, Pigneux A, Bernard F, Larch\u00e9 J, Monchecourt F, Alfandari S, Mahi L: Liposomal amphotericin B in combination with caspofungin for invasive aspergillosis in patients with hematologic malignancies: a randomized pilot study (Combistrat trial). Cancer 2007, 110: 2740\u20132746. 10.1002\/cncr.23109","journal-title":"Cancer"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/2047-783X-17-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/2047-783X-17-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/2047-783X-17-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,22]],"date-time":"2019-01-22T21:24:44Z","timestamp":1548192284000},"score":1,"resource":{"primary":{"URL":"https:\/\/eurjmedres.biomedcentral.com\/articles\/10.1186\/2047-783X-17-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4,17]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["6"],"URL":"https:\/\/doi.org\/10.1186\/2047-783x-17-7","relation":{},"ISSN":["2047-783X"],"issn-type":[{"value":"2047-783X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,4,17]]},"article-number":"7"}}